Skip to main content
FinSpry Logo
FinSpry
XTNT logo
XTNT
(NYSEAMERICAN)
Xtant Medical Holdings, Inc.
$0.45-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Xtant Medical Holdings (XTNT) Stock Price & Financial Analysis

Xtant Medical Holdings Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$0.45 - $0.45
52-Week High$0.95
52-Week Low$0.44
Open$0.45
Volume94.60K
Average Volume (3M)146.18K
Market Cap68.40M
Shares Outstanding150.04M
P/E Ratio (TTM)13.76
Price to Sales (P/S)0.51
Price to Book (P/B)1.34
EV/EBITDA4.53
Revenue (TTM)133.38M
Net Income (TTM)4.97M
Free Cash Flow (TTM)15.06M
EPS (TTM)$0.03
Profit Margin3.73%
Operating Margin3.96%
Return on Equity (ROE)9.76%
Debt to Equity0.56
50-Day MA$0.50
200-Day MA$0.63
52-Week Change-35.47%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Xtant Medical Holdings

What is the current stock price for XTNT?

As of the latest trading session, XTNT stock trades at $0.45. The 52-week range is $0.44–$0.95, with a day range of $0.45–$0.45.

What is the P/E ratio for XTNT?

Xtant Medical Holdings's trailing P/E ratio is 13.8, meaning investors pay $13.8 for every $1 of annual earnings. Xtant Medical Holdings operates in the Healthcare sector.

Does XTNT pay dividends?

Xtant Medical Holdings does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for XTNT?

Based on 1 analyst, the consensus for XTNT is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of XTNT?

Xtant Medical Holdings's market capitalization is $67.3M, classifying it as a micro-cap company. Xtant Medical Holdings operates in the Healthcare sector within the Medical Devices industry.